SPDR S&P PHARMA ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
A Look At Pharma ETFs Post Q4 Results
Article By: Sweta Killa
Thursday, February 7, 2019 1:47 PM EDT
The strong results but downbeat guidance led to decent returns in the pharma ETFs over the past month. Here they are in detail.
In this article: IHE, XPH, PPH, PJP, FTXH Also: JNJ, PFE, MRK, BMY, LLY
Read
Beaten-Down Pharma ETFs To Buy Post Q3 Results
Article By: Sweta Killa
Tuesday, November 6, 2018 2:59 PM EDT
Total earnings for 76.7% of the total healthcare market capitalization are up 11% on revenue growth of 7.2%. The growth rates seem unimpressive when compared with some of the other sectors.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, MRK, PFE
Read
AI And The New Health Care
Article By: John Thomas
Friday, September 28, 2018 3:34 AM EDT
The first major industry to be fundamentally disrupted by AI will be health care. The next step in our intellectual evolution will be carried out by AI. By connecting our neocortex to the Internet, we will greatly improve our intelligence.
In this article: BMY, MRK, PFE, XLV, XPH
Read
Q2 Earnings Drive Pharma ETFs Higher
Article By: Sweta Killa
Tuesday, August 7, 2018 12:23 PM EDT
Total earnings for 83.5% of the total healthcare market capitalization are up 13.7% on revenue growth of 7.8%.
In this article: IHE, PJP, PPH, XPH, FTXH Also: BMY, JNJ, LLY, MRK, PFE
Read
Biotech Year One: A Year Of Trials Tribulations And Discovery
Article By: Kieran O'Dea
Monday, December 25, 2017 8:24 AM EDT
The biotech market is its own beast, derived from the aggregate opinions and knowledge of the mainstream thought. The market has a binary, linear, and simplistic approach to trial results ignoring the context in which each trial is conducted.
In this article: IBB, XBI, XPH, SPY, TEVA, AGN, JNJ, MYL, BMY, BIIB, PFE, MRK, INCY
Read

PARTNER HEADLINES

Latest Tweets for $XPH

No tweets yet!